These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28558028)

  • 21. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
    Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
    Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.
    Turco D; Severi S; Mignani R; Aiello V; Magistroni R; Corsi C
    Acad Radiol; 2015 Nov; 22(11):1376-84. PubMed ID: 26276168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.
    Sise C; Kusaka M; Wetzel LH; Winklhofer F; Cowley BD; Cook LT; Gordon M; Grantham JJ
    Kidney Int; 2000 Dec; 58(6):2492-501. PubMed ID: 11115083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease.
    Sharma K; Rupprecht C; Caroli A; Aparicio MC; Remuzzi A; Baust M; Navab N
    Sci Rep; 2017 May; 7(1):2049. PubMed ID: 28515418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements.
    Jagtap JM; Gregory AV; Homes HL; Wright DE; Edwards ME; Akkus Z; Erickson BJ; Kline TL
    Abdom Radiol (NY); 2022 Jul; 47(7):2408-2419. PubMed ID: 35476147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
    J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
    O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP
    Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model.
    Yu Y; Shumway KL; Matheson JS; Edwards ME; Kline TL; Lyons LA
    BMC Nephrol; 2019 Jul; 20(1):259. PubMed ID: 31299928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.
    Bae K; Park B; Sun H; Wang J; Tao C; Chapman AB; Torres VE; Grantham JJ; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1089-97. PubMed ID: 23520042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.
    Cadnapaphornchai MA; Masoumi A; Strain JD; McFann K; Schrier RW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):369-76. PubMed ID: 21115621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.
    Muto S; Kawano H; Isotani S; Ide H; Horie S
    Clin Exp Nephrol; 2018 Jun; 22(3):583-590. PubMed ID: 29101551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volume regression of native polycystic kidneys after renal transplantation.
    Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
    Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease.
    Higashihara E; Nutahara K; Okegawa T; Tanbo M; Hara H; Miyazaki I; Kobayasi K; Nitatori T
    Nephron; 2015; 129(4):253-62. PubMed ID: 25895545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonographic renal volume measurements in early autosomal dominant polycystic disease: comparison with CT-scan renal volume calculations.
    Hammoud S; Tissier AM; Elie C; Pousset M; Knebelman B; Joly D; Hélénon O; Correas JM
    Diagn Interv Imaging; 2015 Jan; 96(1):65-71. PubMed ID: 25547671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
    King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD.
    Demoulin N; Nicola V; Michoux N; Gillion V; Ho TA; Clerckx C; Pirson Y; Annet L
    Kidney Int Rep; 2021 Nov; 6(11):2821-2829. PubMed ID: 34805634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.
    Lee YR; Lee KB
    Nephron Clin Pract; 2006; 103(4):c173-80. PubMed ID: 16636585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
    Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
    Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.